Financial Gravity Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Financial Gravity Asset Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-34	Closed	-$3.14K	–	995
2021 Q1	$3.14K	Buy	+34	New	+$3.21K	0.06%	192
2020 Q2	–	Sell	-6	Closed	-$305	–	487
2020 Q1	$305	Sell	6 -8	-57%	-$453	﹤0.01%	644
2019 Q4	$104K	Hold	14	–	–	0.07%	304
2019 Q3	$1K	Hold	14	–	–	﹤0.01%	1054
2019 Q2	$1K	Sell	14 -640	-98%	-$47.1K	﹤0.01%	1075
2019 Q1	$51K	Buy	+654	New	+$49.5K	0.04%	312
2018 Q3	$33K	Buy	319 +303	+1,894%	+$45.7K	0.03%	414
2018 Q2	$2K	Buy	16 +5	+45%	+$558	﹤0.01%	1004
2018 Q1	$1K	Buy	+11	New	+$1.09K	﹤0.01%	1185

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Financial Gravity Asset Management's LGND Position: Q2 2021 in Review

Financial Gravity Asset Management sold out of Ligand Pharmaceuticals (LGND) in Q2 2021, closing a stake of 34 shares — an estimated $3.14K sold.

Financial Gravity Asset Management first reported a position in LGND in Q1 2018 and held it in 9 quarters. The position peaked at $104K in Q4 2019. 212 funds tracked by Wall St. Rank hold LGND as of Q2 2021.

Financial Gravity Asset Management reported no remaining Ligand Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Financial Gravity Asset Management sold 34 Ligand Pharmaceuticals shares in Q2 2021, an estimated $3.14K.
Financial Gravity Asset Management first reported a position in Ligand Pharmaceuticals in Q1 2018 and held it in 9 quarters.
Financial Gravity Asset Management's Ligand Pharmaceuticals position peaked at $104K in Q4 2019.
212 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2021.

Based on Financial Gravity Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.